• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡介苗能否成为预防新冠疫情感染及严重程度的变革性手段?

BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?

作者信息

Sharma A R, Batra G, Kumar M, Mishra A, Singla R, Singh A, Singh R S, Medhi B

机构信息

Post Graduate Institute for Medical Education and Research (PGIMER), Chandigarh, India; Department of Neurology, India.

Post Graduate Institute for Medical Education and Research (PGIMER), Chandigarh, India; Department of Pharmacology, India.

出版信息

Allergol Immunopathol (Madr). 2020 Sep-Oct;48(5):507-517. doi: 10.1016/j.aller.2020.05.002. Epub 2020 Jul 3.

DOI:10.1016/j.aller.2020.05.002
PMID:32653224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7332934/
Abstract

The impact of COVID-19 is changing with country wise and depend on universal immunization policies. COVID-19 badly affects countries that did not have universal immunization policies or having them only for the selective population of countries (highly prominent population) like Italy, USA, UK, Netherland, etc. Universal immunization of BCG can provide great protection against the COVID-19 infection because the BCG vaccine gives broad protection against respiratory infections. BCG vaccine induces expressions of the gene that are involved in the antiviral innate immune response against viral infections with long-term maintenance of BCG vaccine-induced cellular immunity. COVID-19 cases are reported very much less in the countries with universal BCG vaccination policies such as India, Afghanistan, Nepal, Bhutan, Bangladesh, Israel, Japan, etc. as compared to without BCG implemented countries such as the USA, Italy, Spain, Canada, UK, etc. BCG vaccine provides protection for 50-60 years of immunization, so the elderly population needs to be revaccinated with BCG. Several countries started clinical trials of the BCG vaccine for health care workers and elderly people. BCG can be uses as a prophylactic treatment until the availability of the COVID-19 vaccine.

摘要

新冠疫情的影响因国家而异,取决于全民免疫政策。新冠疫情对那些没有全民免疫政策,或者仅针对本国特定人群(如意大利、美国、英国、荷兰等国的高危人群)实施免疫政策的国家造成了严重影响。卡介苗的全民免疫可以为预防新冠病毒感染提供强大保护,因为卡介苗能广泛预防呼吸道感染。卡介苗可诱导参与抗病毒先天免疫反应的基因表达,以长期维持卡介苗诱导的细胞免疫,从而抵御病毒感染。与未实施卡介苗接种的国家(如美国、意大利、西班牙、加拿大、英国等)相比,在实施卡介苗全民接种政策的国家(如印度、阿富汗、尼泊尔、不丹、孟加拉国、以色列、日本等),新冠病例的报告数量要少得多。卡介苗提供50至60年的免疫保护,因此老年人群需要重新接种卡介苗。一些国家已针对医护人员和老年人启动了卡介苗的临床试验。在新冠疫苗可用之前,卡介苗可作为一种预防性治疗手段。

相似文献

1
BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?卡介苗能否成为预防新冠疫情感染及严重程度的变革性手段?
Allergol Immunopathol (Madr). 2020 Sep-Oct;48(5):507-517. doi: 10.1016/j.aller.2020.05.002. Epub 2020 Jul 3.
2
Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.卡介苗(BCG)接种在 COVID-19 大流行死亡率中的潜在作用:流行病学和免疫学方面。
Asian Pac J Allergy Immunol. 2020 Sep;38(3):150-161. doi: 10.12932/AP-310520-0863.
3
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.在新冠疫情期间使用卡介苗增强医护人员的非特异性防护:丹麦一项随机对照试验研究方案的结构化总结
Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.
4
Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?卡介苗免疫接种能阻止新冠疫情吗?
Indian J Med Res. 2020;152(1 & 2):16-20. doi: 10.4103/ijmr.IJMR_1563_20.
5
Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?BCG 疫苗接种能否诱导针对 SARS-CoV-2 的保护性训练免疫?
Front Immunol. 2020 May 8;11:970. doi: 10.3389/fimmu.2020.00970. eCollection 2020.
6
Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.BCG 疫苗针对 SARS-CoV-2 再利用的生物学基础。
J Proteome Res. 2020 Nov 6;19(11):4649-4654. doi: 10.1021/acs.jproteome.0c00410. Epub 2020 Aug 28.
7
COVID-19 and Bacillus Calmette-Guérin: What is the Link?新型冠状病毒肺炎与卡介苗:有何关联?
Eur Urol Oncol. 2020 Jun;3(3):259-261. doi: 10.1016/j.euo.2020.04.001. Epub 2020 Apr 13.
8
A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality.一种用于药物和疫苗重新利用的系统生物学工作流程:鉴定小分子卡介苗类似物以降低或预防 COVID-19 死亡率。
Pharm Res. 2020 Oct 6;37(11):212. doi: 10.1007/s11095-020-02930-9.
9
The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.卡介苗(BCG)接种对COVID-19发病率和死亡率的影响——文献综述
Przegl Epidemiol. 2020;74(2):290-302. doi: 10.32394/pe.74.22.
10
Demand for BCG Vaccine Due to Unproven Claims of its Role in Preventing COVID-19 Is Causing Shortages of Vaccines for Infants in Japan.由于卡介苗在预防新冠病毒方面的作用未经证实,其需求导致日本婴儿疫苗短缺。
Pediatr Infect Dis J. 2020 Jul;39(7):e159-e160. doi: 10.1097/INF.0000000000002724.

引用本文的文献

1
BCG immunization mitigates SARS-CoV-2 replication in macaques via monocyte efferocytosis and neutrophil recruitment in lungs.卡介苗免疫通过单核细胞胞葬作用和肺部中性粒细胞募集减轻猕猴体内的新冠病毒复制。
JCI Insight. 2025 Aug 8;10(15). doi: 10.1172/jci.insight.194633.
2
The underlying mechanism behind the different outcomes of COVID-19 in children and adults.新冠病毒感染在儿童和成人中产生不同结果背后的潜在机制。
Front Immunol. 2025 Apr 30;16:1440169. doi: 10.3389/fimmu.2025.1440169. eCollection 2025.
3
COVID-19-Related Age Profiles for SARS-CoV-2 Variants in England and Wales and States of the USA (2020 to 2022): Impact on All-Cause Mortality.英格兰、威尔士及美国各州(2020年至2022年)新冠病毒变异株相关的COVID-19年龄分布情况:对全因死亡率的影响
Infect Dis Rep. 2023 Oct 8;15(5):600-634. doi: 10.3390/idr15050058.
4
Multidimensional futuristic approaches to address the pandemics beyond COVID-19.应对新冠疫情之外的大流行病的多维未来主义方法。
Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.
5
Relationship between Tuberculin Skin Test and COVID-19 Outcomes among Patients with COVID-19 in Zahedan, Iran.伊朗扎黑丹新冠肺炎患者结核菌素皮肤试验与新冠肺炎结局的关系
Tanaffos. 2022 Feb;21(2):154-160.
6
Fiction and Facts about BCG Imparting Trained Immunity against COVID-19.关于卡介苗赋予针对新冠病毒的训练有素的免疫力的虚构与事实
Vaccines (Basel). 2022 Jun 23;10(7):1006. doi: 10.3390/vaccines10071006.
7
Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的口服和鼻内疫苗:当前进展、前景、优势及挑战
Immun Inflamm Dis. 2022 Apr;10(4):e604. doi: 10.1002/iid3.604.
8
Does Bacille Calmette-Guérin Vaccination Provides Protection against COVID-19: A Systematic Review and Meta-analysis.卡介苗接种能否预防新型冠状病毒肺炎:一项系统评价与Meta分析
Indian J Community Med. 2021 Oct-Dec;46(4):592-599. doi: 10.4103/ijcm.IJCM_952_20. Epub 2021 Dec 8.
9
Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population.卡介苗接种人群中新冠病毒肺炎的严重程度
Clin Exp Vaccine Res. 2021 Sep;10(3):276-281. doi: 10.7774/cevr.2021.10.3.276. Epub 2021 Sep 30.
10
COVID-19 and Beyond: Exploring Public Health Benefits from Non-Specific Effects of BCG Vaccination.新冠疫情及未来:探索卡介苗接种非特异性效应带来的公共卫生益处。
Microorganisms. 2021 Oct 9;9(10):2120. doi: 10.3390/microorganisms9102120.

本文引用的文献

1
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸系统综合征冠状病毒 2 刺突糖蛋白的结构、功能和抗原性。
Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9.
2
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情,该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
3
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例,提示存在人际传播:一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
4
Structural insights into coronavirus entry.冠状病毒进入的结构见解。
Adv Virus Res. 2019;105:93-116. doi: 10.1016/bs.aivir.2019.08.002. Epub 2019 Aug 22.
5
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.细菌蛋白 Toll 样受体激动剂:疫苗佐剂的新视角。
Front Immunol. 2019 May 29;10:1144. doi: 10.3389/fimmu.2019.01144. eCollection 2019.
6
Non-specific effects of BCG vaccine on viral infections.卡介苗疫苗对病毒感染的非特异性作用。
Clin Microbiol Infect. 2019 Dec;25(12):1473-1478. doi: 10.1016/j.cmi.2019.04.020. Epub 2019 May 2.
7
The Mycobacterium tuberculosis glycoprotein Rv1016c protein inhibits dendritic cell maturation, and impairs Th1 /Th17 responses during mycobacteria infection.结核分枝杆菌糖蛋白 Rv1016c 蛋白抑制树突状细胞成熟,并在分枝杆菌感染期间损害 Th1/Th17 反应。
Mol Immunol. 2019 May;109:58-70. doi: 10.1016/j.molimm.2019.02.021. Epub 2019 Mar 8.
8
Mycobacterial growth inhibition is associated with trained innate immunity.分枝杆菌生长抑制与训练有素的先天免疫有关。
J Clin Invest. 2018 May 1;128(5):1837-1851. doi: 10.1172/JCI97508. Epub 2018 Apr 3.
9
Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses.BCG Hip1 蛋白酶缺失增强树突状细胞和 CD4 T 细胞应答。
J Leukoc Biol. 2018 Apr;103(4):739-748. doi: 10.1002/JLB.4A0917-363RR. Epub 2017 Dec 28.
10
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity.BCG 疫苗接种通过诱导与训练有素的免疫相关的细胞因子来保护人类免受实验性病毒感染。
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5. doi: 10.1016/j.chom.2017.12.010.